Lymphomatoid papulosis
Rachel S. Klein, Elisha Singer, Jacqueline M. Junkins-Hopkins, Carmela C. Vittorio, Alain H. Rook and Ellen J. Kim

Specific investigations
CD30+ cutaneous lymphoproliferative disorders: the Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma.
Liu HL, Hoppe RT, Kohler S, Harvell JD, Reddy S, Kim YH. J Am Acad Dermatol 2003; 49: 1049–58.
The higher association with malignancy may represent selection bias.
First-line therapies
EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.
Kempf W, Pfaltz K, Vermeer M, Cozzio A, Ortiz-Romero P, Bagot M, et al. Blood 2011; 118: 4024–35.
Third-line therapies